Allergan (AGN) Tops Q4 EPS by 12c, Reports Mixed FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. AAPL
3. JNJ
4. AMAT
5. META
6. NRIX
7. SUNS
8. SPY
9. SNDX
10. CRDO

Go back to Allergan (AGN) Tops Q4 EPS by 12c, Reports Mixed FY Guidance

Allergen (AGN) PT Raised to $215 at Credit Suisse; 'Positive CGRP Data Should Relieve Pain AGN Investors Have Been Feeling'

February 7, 2018 8:12 AM EST

Credit Suisse raised its price target on Allergen (NYSE: AGN) to $215.00 (from $214.00) while maintaining a Outperform rating.

... More

Allergen (AGN) PT Raised to $242 at Leerink Partners

February 7, 2018 7:39 AM EST

Leerink Partners raised its price target on Allergen (NYSE: AGN) to $242.00 (from $237.00) while maintaining a Outperform rating.

Analyst Seamus Fernandez commented, "Following Tuesdays call we are incrementally more confident in the approvability of ubrogepant for acute migraine and AGNs ability to execute on 2018... More